Results
30
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
30 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2111 | HK$2.17 | -0.9% | 114.9% | HK$2.2b | HK$1.93 | PE6.5x | E24.3% | 7.7% | Consumer Durables | ||
1119 | HK$2.18 | -8.4% | -33.9% | HK$3.7b | HK$4.84 | PS1.7x | E104.1% | n/a | Media | ||
285 | HK$27.65 | -6.7% | -8.1% | HK$62.4b | HK$43.51 | PE14.1x | E22.3% | 2.1% | Tech | ||
2013 | HK$1.17 | 0.9% | -69.5% | HK$3.6b | HK$2.32 | PS1.5x | E109.9% | n/a | Software | ||
3393 | HK$5.83 | -6.9% | 98.3% | HK$5.7b | HK$6.90 | PE10.2x | E25.8% | 4.8% | Tech | ||
1382 | HK$1.64 | -1.2% | -15.5% | HK$2.2b | HK$3.32 | PE13.7x | E37.7% | 7.3% | Consumer Durables | ||
596 | HK$3.18 | 8.9% | 18.7% | HK$3.3b | HK$5.00 | PE16.5x | E38.0% | 0.9% | Software | ||
1801 | HK$41.30 | 12.2% | 43.9% | HK$65.1b | HK$56.77 | PS9.9x | E50.5% | n/a | Pharmaceuticals & Biotech | ||
3998 | HK$3.87 | 1.8% | 12.8% | HK$42.3b | HK$5.58 | PE12.7x | E12.8% | 6.5% | Consumer Durables | ||
2160 | HK$0.79 | 11.3% | -62.4% | HK$1.7b | HK$2.19 | PS5.2x | E98.6% | n/a | Healthcare | ||
973 | HK$33.50 | -1.0% | 31.4% | HK$50.1b | HK$33.58 | PE61.6x | E25.6% | 0% | Household | ||
1911 | HK$7.27 | 0% | -26.2% | HK$4.1b | HK$12.69 | PS2.6x | E97.8% | 5.7% | Diversified Financials | ||
2325 | HK$8.10 | -8.5% | -34.0% | HK$5.0b | HK$13.99 | PS5x | E97.8% | 0.2% | Healthcare | ||
799 | HK$2.67 | -1.5% | -30.5% | HK$3.0b | HK$4.22 | PE41.4x | E51.2% | n/a | Media | ||
6616 | HK$3.85 | 2.7% | -12.7% | HK$4.7b | HK$5.83 | PE24.1x | E41.8% | 0% | Materials | ||
9886 | HK$1.10 | 18.3% | -60.6% | HK$1.3b | HK$1.56 | PB0.7x | E84.4% | n/a | Consumer Retailing | ||
1548 | HK$13.02 | 9.8% | -32.7% | HK$25.3b | HK$24.14 | PS4.2x | E97.9% | 0% | Pharmaceuticals & Biotech | ||
2400 | HK$22.75 | 3.6% | 32.6% | HK$10.1b | HK$21.39 | PS2.9x | E54.2% | n/a | Media | ||
1952 | HK$19.80 | 8.3% | 9.4% | HK$6.0b | HK$26.07 | PS46.2x | E76.3% | n/a | Pharmaceuticals & Biotech | ||
9923 | HK$10.66 | -2.4% | -38.6% | HK$4.6b | HK$15.72 | PE359.5x | E51.5% | n/a | Diversified Financials | ||
1516 | HK$1.67 | -1.2% | -26.8% | HK$5.0b | HK$1.87 | PB0.8x | E60.4% | 9.4% | Real Estate Management and Development | ||
2382 | HK$40.30 | -3.5% | -42.2% | HK$43.0b | HK$65.72 | PE36.5x | E24.6% | 0.5% | Tech | ||
1821 | HK$11.26 | -1.6% | -13.0% | HK$46.4b | HK$15.43 | PE29.9x | E26.3% | 2.2% | Real Estate Management and Development | ||
2018 | HK$24.60 | -13.1% | 43.5% | HK$30.9b | HK$30.57 | PE36.5x | E23.7% | 0.4% | Tech |